Stay updated on ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Sign up to get notified when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.

Latest updates to the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page
- Check2 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0, while the study record remains inaccessible with a 403 Forbidden message.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check16 days agoChange DetectedThe error page’s footer revision identifier changed from v3.7.1 to v3.7.2; the page content and layout remain unchanged.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 error.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with a standard error page. As a result, the main study details and attached documents are inaccessible on this page.SummaryDifference18%

- Check65 days agoChange DetectedThe revision stamp updated from v3.6.5 to v3.6.6, indicating a small page version update. No visible changes to study details or layout are described.SummaryDifference0.1%

Stay in the know with updates to ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.